Annual CAPEX
$21.57 M
-$46.43 M-68.28%
December 31, 2023
Summary
- As of February 7, 2025, VIR annual capital expenditures is $21.57 million, with the most recent change of -$46.43 million (-68.28%) on December 31, 2023.
- During the last 3 years, VIR annual CAPEX has risen by +$15.02 million (+229.41%).
- VIR annual CAPEX is now -68.28% below its all-time high of $68.01 million, reached on December 31, 2022.
Performance
VIR CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$2.36 M
+$1.69 M+253.75%
September 30, 2024
Summary
- As of February 7, 2025, VIR quarterly capital expenditures is $2.36 million, with the most recent change of +$1.69 million (+253.75%) on September 30, 2024.
- Over the past year, VIR quarterly CAPEX has increased by +$1.69 million (+253.75%).
- VIR quarterly CAPEX is now -88.56% below its all-time high of $20.60 million, reached on June 30, 2022.
Performance
VIR Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$6.43 M
-$1.36 M-17.44%
September 30, 2024
Summary
- As of February 7, 2025, VIR TTM capital expenditures is $6.43 million, with the most recent change of -$1.36 million (-17.44%) on September 30, 2024.
- Over the past year, VIR TTM CAPEX has dropped by -$1.36 million (-17.44%).
- VIR TTM CAPEX is now -90.61% below its all-time high of $68.50 million, reached on September 30, 2022.
Performance
VIR TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
VIR CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -68.3% | +253.8% | -17.4% |
| 3 y3 years | +229.4% | -65.7% | -89.1% |
| 5 y5 years | +163.3% | -65.7% | -89.1% |
VIR CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -68.3% | at low | -88.6% | +253.8% | -90.6% | at low |
| 5 y | 5-year | -68.3% | +229.4% | -88.6% | +253.8% | -90.6% | +17.9% |
| alltime | all time | -68.3% | +686.8% | -88.6% | +253.8% | -90.6% | +85.0% |
Vir Biotechnology CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.36 M(+253.8%) | $6.43 M(-17.4%) |
| Jun 2024 | - | $666.00 K(-64.4%) | $7.79 M(-53.0%) |
| Mar 2024 | - | $1.87 M(+22.0%) | $16.58 M(-23.2%) |
| Dec 2023 | $21.57 M(-68.3%) | $1.53 M(-58.7%) | $21.57 M(-33.8%) |
| Sep 2023 | - | $3.71 M(-60.7%) | $32.61 M(-31.9%) |
| Jun 2023 | - | $9.46 M(+37.7%) | $47.89 M(-18.9%) |
| Mar 2023 | - | $6.87 M(-45.4%) | $59.03 M(-13.2%) |
| Dec 2022 | $68.01 M(+211.7%) | $12.57 M(-33.8%) | $68.01 M(-0.7%) |
| Sep 2022 | - | $18.99 M(-7.8%) | $68.50 M(+23.4%) |
| Jun 2022 | - | $20.60 M(+30.0%) | $55.51 M(+50.1%) |
| Mar 2022 | - | $15.84 M(+21.2%) | $36.99 M(+69.6%) |
| Dec 2021 | $21.82 M | $13.07 M(+117.6%) | $21.82 M(+95.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $6.01 M(+189.2%) | $11.18 M(+68.2%) |
| Jun 2021 | - | $2.08 M(+211.4%) | $6.65 M(+12.4%) |
| Mar 2021 | - | $667.00 K(-72.6%) | $5.91 M(-9.7%) |
| Dec 2020 | $6.55 M(-26.7%) | $2.43 M(+64.9%) | $6.55 M(+15.5%) |
| Sep 2020 | - | $1.47 M(+9.8%) | $5.67 M(+4.0%) |
| Jun 2020 | - | $1.34 M(+3.1%) | $5.45 M(-19.4%) |
| Mar 2020 | - | $1.30 M(-16.1%) | $6.77 M(-24.3%) |
| Dec 2019 | $8.94 M(+9.1%) | $1.55 M(+23.5%) | $8.94 M(+21.0%) |
| Sep 2019 | - | $1.26 M(-52.7%) | $7.39 M(+20.5%) |
| Jun 2019 | - | $2.65 M(-23.6%) | $6.13 M(+76.4%) |
| Mar 2019 | - | $3.48 M | $3.48 M |
| Dec 2018 | $8.19 M(+198.8%) | - | - |
| Dec 2017 | $2.74 M | - | - |
FAQ
- What is Vir Biotechnology annual capital expenditures?
- What is the all time high annual CAPEX for Vir Biotechnology?
- What is Vir Biotechnology annual CAPEX year-on-year change?
- What is Vir Biotechnology quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Vir Biotechnology?
- What is Vir Biotechnology quarterly CAPEX year-on-year change?
- What is Vir Biotechnology TTM capital expenditures?
- What is the all time high TTM CAPEX for Vir Biotechnology?
- What is Vir Biotechnology TTM CAPEX year-on-year change?
What is Vir Biotechnology annual capital expenditures?
The current annual CAPEX of VIR is $21.57 M
What is the all time high annual CAPEX for Vir Biotechnology?
Vir Biotechnology all-time high annual capital expenditures is $68.01 M
What is Vir Biotechnology annual CAPEX year-on-year change?
Over the past year, VIR annual capital expenditures has changed by -$46.43 M (-68.28%)
What is Vir Biotechnology quarterly capital expenditures?
The current quarterly CAPEX of VIR is $2.36 M
What is the all time high quarterly CAPEX for Vir Biotechnology?
Vir Biotechnology all-time high quarterly capital expenditures is $20.60 M
What is Vir Biotechnology quarterly CAPEX year-on-year change?
Over the past year, VIR quarterly capital expenditures has changed by +$1.69 M (+253.75%)
What is Vir Biotechnology TTM capital expenditures?
The current TTM CAPEX of VIR is $6.43 M
What is the all time high TTM CAPEX for Vir Biotechnology?
Vir Biotechnology all-time high TTM capital expenditures is $68.50 M
What is Vir Biotechnology TTM CAPEX year-on-year change?
Over the past year, VIR TTM capital expenditures has changed by -$1.36 M (-17.44%)